Your Health Plan:
BYOOVIZ (ranibizumab) is a biosimilar prescription drug for treatment of Age related macular degeneration, Retinal Vein Occlusion and Myopic choroidal neovascularization. BYOOVIZ is a vascular endothelial growth factor inhibitor. It is available in the form of intravitreal injection.
See full Prescribing Information for important safety information and clinical studies.
BYOOVIZ is not covered by . Cash price for 30-day supply is $1200-1600.
